The androgen receptor mRNA

被引:57
作者
Yeap, BB
Wilce, JA
Leedman, PJ
机构
[1] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia
[2] Royal Perth Hosp, Perth, WA, Australia
[3] Univ Western Australia, Sch Biomed & Chem Sci, Nedlands, WA 6009, Australia
[4] Univ Western Australia, Lab Canc Med, Med Res Ctr, Nedlands, WA 6009, Australia
[5] Western Australian Inst Med Res, Perth, WA, Australia
关键词
D O I
10.1002/bies.20051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Androgens (testosterone), acting via the androgen receptor (AR) a nuclear transcription factor, regulate male sexual development and body composition. In addition, AR expression plays an important role in the proliferation of human prostate cancer and confers a better prognosis in breast cancer. AR mRNA stability is central to the regulation of AR expression in prostate and breast cancer cells, and recent studies have demonstrated binding by members of the ELAV/Hu and poly(C) RNA-binding protein families to a highly conserved UC-rich element in the X-untranslated region of AR mRNA, with functional impact on AR protein expression. Remarkably, a CAG trinucleotide repeat in exon 1 of the AR, the length of which has been linked to prostate cancer survival, is also a target for multiple RNA-binding proteins from a variety of human and murine tissues. In this review, we will detail the current knowledge of the mechanisms involved in regulating AR mRNA stability, the nature, potential role and structural biology of several novel AR mRNA-protein interactions, and the implications for novel therapeutics in human prostate cancer. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:672 / 682
页数:11
相关论文
共 97 条
[1]   HADHB, HuR, and CP1 bind to the distal 3′-untranslated region of human renin mRNA and differentially modulate renin expression [J].
Adams, DJ ;
Beveridge, DJ ;
van der Weyden, L ;
Mangs, H ;
Leedman, PJ ;
Morris, BJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :44894-44903
[2]   Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men [J].
Balic, I ;
Graham, ST ;
Troyer, DA ;
Higgins, BA ;
Pollock, BH ;
Johnson-Pais, TL ;
Thompson, IM ;
Leach, RJ .
JOURNAL OF UROLOGY, 2002, 168 (05) :2245-2248
[3]   Identification of a novel AU-rich element in the 3′ untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins [J].
Balmer, LA ;
Beveridge, DJ ;
Jazayeri, JA ;
Thomson, AM ;
Walker, CE ;
Leedman, PJ .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (06) :2070-2084
[4]   Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells [J].
Bentel, JM ;
Birrell, SN ;
Pickering, MA ;
Holds, DJ ;
Horsfall, DJ ;
Tilley, WD .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 154 (1-2) :11-20
[5]   MEDROXYPROGESTERONE ACETATE THERAPY IN ADVANCED BREAST-CANCER - THE PREDICTIVE VALUE OF ANDROGEN RECEPTOR EXPRESSION [J].
BIRRELL, SN ;
RODER, DM ;
HORSFALL, DJ ;
BENTEL, JM ;
TILLEY, WD .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) :1572-1577
[6]   HuR and mRNA stability [J].
Brennan, CM ;
Steitz, JA .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (02) :266-277
[7]   Molecular basis of androgen insensitivity [J].
Brinkmann, AO .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 179 (1-2) :105-109
[8]   Implications of a polyglutamine tract in the function of the human androgen receptor [J].
Callewaert, L ;
Christiaens, V ;
Haelens, A ;
Verrijdt, G ;
Verhoeven, G ;
Claessens, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (01) :46-52
[9]   THE LENGTH AND LOCATION OF CAG TRINUCLEOTIDE REPEATS IN THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN AFFECT TRANSACTIVATION FUNCTION [J].
CHAMBERLAIN, NL ;
DRIVER, ED ;
MIESFELD, RL .
NUCLEIC ACIDS RESEARCH, 1994, 22 (15) :3181-3186
[10]  
Chen C, 2002, CANCER EPIDEM BIOMAR, V11, P1033